• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘中的黏液过度分泌与鼻窦炎、息肉和加重有关。

Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.

机构信息

Department of Respiratory Medicine, Hospital Universitari Germans TriasiPujol, Badalona, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red Enfermedades Respirtorias (CIBERES), Barcelona, Spain.

Department of Pneumology, Hospital de la Santa CreuiSant Pau, Institute Sant Pau Biomedical Research (IBB Sant Pau), Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en red Enfermedades Respirtorias (CIBERES), Barcelona, Spain.

出版信息

Respir Med. 2018 Feb;135:22-28. doi: 10.1016/j.rmed.2017.12.013. Epub 2018 Jan 3.

DOI:10.1016/j.rmed.2017.12.013
PMID:29414449
Abstract

BACKGROUND

Bronchial hypersecretion is a poorly studied symptom in asthma. The aim of the study was to determine the specific characteristics of asthmatics with bronchial hypersecretion.

METHODS

A total of 142 asthmatics (21.8% men; mean age 49.8 years) were prospectively followed for one year. Mucus hypersecretion was clinically classified into two severity categories: daily sputum production and frequent expectoration but not every day. Clinical and pulmonary function variables associated with mucus hypersecretion were assessed by multiple logistic regression analysis.

RESULTS

Daily cough was recorded in 28.9% of patients and sputum production daily or most of the days in 52.1%. Patients with mucus hypersecretion had more dyspnoea, poorer asthma control and quality of life, had suffered from more exacerbations and showed anosmia associated with chronic rhinosinusitis and nasal polyposis more frequently. Factors associated to mucus hypersecretion were anosmia, one exacerbation or more in the previous year and FEV1/FVC <70% (AUC 0.75, 95% CI 0.66-0.85) for the first definition of hypersecretion, and anosmia, poor asthma control and age (AUC 0.75, 95% CI 0.67-0.83) for the second definition.

CONCLUSIONS

Mucus hypersecretion is frequent in patients with asthma, and is associated with chronic upper airways disease, airway obstruction, poor asthma control and more exacerbations.

摘要

背景

支气管过度分泌是哮喘中研究较少的症状。本研究旨在确定支气管过度分泌的哮喘患者的具体特征。

方法

共前瞻性随访 142 名哮喘患者(21.8%为男性;平均年龄 49.8 岁)一年。通过多项逻辑回归分析评估了粘液过度分泌的临床严重程度分类(每日咳痰和频繁咳痰但非每天)与临床和肺功能变量的相关性。

结果

28.9%的患者记录有每日咳嗽,52.1%的患者每日或多数日子有痰生成。粘液过度分泌的患者呼吸困难更严重,哮喘控制和生活质量更差,过去一年中发生过更多次加重,且伴有嗅觉丧失的慢性鼻-鼻窦炎和鼻息肉更为常见。与粘液过度分泌相关的因素包括嗅觉丧失、过去一年中发生过一次或多次加重以及 FEV1/FVC<70%(第一个过度分泌定义的 AUC 为 0.75,95%CI 为 0.66-0.85),以及嗅觉丧失、哮喘控制不佳和年龄(第二个过度分泌定义的 AUC 为 0.75,95%CI 为 0.67-0.83)。

结论

哮喘患者中粘液过度分泌很常见,与慢性上呼吸道疾病、气道阻塞、哮喘控制不佳和更多加重有关。

相似文献

1
Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.哮喘中的黏液过度分泌与鼻窦炎、息肉和加重有关。
Respir Med. 2018 Feb;135:22-28. doi: 10.1016/j.rmed.2017.12.013. Epub 2018 Jan 3.
2
Chronic cough and sputum production are associated with worse clinical outcomes in stable asthma.慢性咳嗽和咳痰与稳定期哮喘的临床结局恶化相关。
Respir Med. 2013 Oct;107(10):1501-8. doi: 10.1016/j.rmed.2013.07.017. Epub 2013 Aug 6.
3
Association of the CFTR gene with asthma and airway mucus hypersecretion.CFTR 基因与哮喘和气道黏液高分泌的关联。
PLoS One. 2021 Jun 4;16(6):e0251881. doi: 10.1371/journal.pone.0251881. eCollection 2021.
4
Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD.噻托溴铵对慢性阻塞性肺疾病患者黏液高分泌及气道清除功能的影响。
Pulm Pharmacol Ther. 2016 Aug;39:81-4. doi: 10.1016/j.pupt.2016.06.008. Epub 2016 Jun 24.
5
Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers.慢性鼻窦炎伴鼻息肉与哮喘的关联:临床与影像学特征、过敏及炎症标志物
Medicina (Kaunas). 2008;44(4):257-65.
6
Upper respiratory symptoms worsen over time and relate to clinical phenotype in chronic obstructive pulmonary disease.上呼吸道症状会随着时间推移而加重,且与慢性阻塞性肺疾病的临床表型相关。
Ann Am Thorac Soc. 2015 Jul;12(7):997-1004. doi: 10.1513/AnnalsATS.201408-359OC.
7
Airway mucus hypersecretion in asthma: an undervalued pathology?哮喘中的气道黏液高分泌:一种被低估的病理状态?
Curr Opin Pharmacol. 2004 Jun;4(3):241-50. doi: 10.1016/j.coph.2004.01.011.
8
Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.慢性阻塞性肺疾病中的黏液病理生理学:与哮喘的差异及药物治疗
Monaldi Arch Chest Dis. 2000 Aug;55(4):324-32.
9
[Clinical features of bronchial asthma with mucus hypersecretion].[黏液高分泌型支气管哮喘的临床特征]
Nihon Kyobu Shikkan Gakkai Zasshi. 1993 May;31(5):575-9.
10
New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.哮喘和 COPD 气道黏液高分泌的新药物治疗:靶向细胞内信号通路。
J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):219-31. doi: 10.1089/jamp.2009.0802.

引用本文的文献

1
The MFGE8/integrin β3 axis mitigates experimental neutrophilic asthma by suppressing NLRP3-Caspase-1 pathway-mediated NETosis.MFGE8/整合素β3轴通过抑制NLRP3-半胱天冬酶-1途径介导的中性粒细胞胞外诱捕网形成来减轻实验性嗜中性粒细胞性哮喘。
Respir Res. 2025 Jul 2;26(1):229. doi: 10.1186/s12931-025-03313-7.
2
Exogenous acetate mitigates later enhanced allergic airway inflammation in a menopausal mouse model.外源性乙酸盐可减轻绝经后小鼠模型中迟发性增强的过敏性气道炎症。
Front Cell Infect Microbiol. 2025 Apr 10;15:1543822. doi: 10.3389/fcimb.2025.1543822. eCollection 2025.
3
The epithelial era of asthma research: knowledge gaps and future direction for patient care.
哮喘研究的上皮细胞时代:患者护理中的知识空白与未来方向。
Eur Respir Rev. 2024 Dec 18;33(174). doi: 10.1183/16000617.0221-2024. Print 2024 Oct.
4
The expression of MUC5AC in patients with rhinosinusitis: A systematic review and meta-analysis.鼻窦炎患者中MUC5AC的表达:一项系统评价和荟萃分析。
Clin Transl Allergy. 2024 Nov;14(11):e70003. doi: 10.1002/clt2.70003.
5
Association of Cough Severity with Asthma Control and Quality of Life in Patients with Severe Asthma.咳嗽严重程度与重度哮喘患者哮喘控制和生活质量的相关性。
Lung. 2024 Aug;202(4):405-414. doi: 10.1007/s00408-024-00710-5. Epub 2024 Jun 7.
6
The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma.气道上皮:炎症的协调者、关键的结构屏障和重症哮喘的治疗靶点。
Eur Respir J. 2024 Apr 4;63(4). doi: 10.1183/13993003.01397-2023. Print 2024 Apr.
7
Experimental studies and mathematical modeling of the viscoelastic rheology of tracheobronchial mucus from respiratory healthy patients.来自呼吸健康患者的气管支气管黏液黏弹性流变学的实验研究与数学建模
Multidiscip Respir Med. 2023 Oct 2;18(1):923. doi: 10.4081/mrm.2023.923. eCollection 2023 Jan 17.
8
Ciliary dyskinesia in severe asthma is not affected by chronic mucus hypersecretion.重度哮喘中的纤毛运动障碍不受慢性黏液分泌过多的影响。
ERJ Open Res. 2023 Oct 2;9(5). doi: 10.1183/23120541.00220-2023. eCollection 2023 Sep.
9
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.慢性气道评估测试:在哮喘和/或 COPD 患者中的心理测量特性。
Respir Res. 2023 Apr 8;24(1):106. doi: 10.1186/s12931-023-02394-6.
10
Altered cell function and increased replication of rhinoviruses and EV-D68 in airway epithelia of asthma patients.哮喘患者气道上皮细胞中鼻病毒和肠道病毒D68的细胞功能改变及复制增加。
Front Microbiol. 2023 Mar 1;14:1106945. doi: 10.3389/fmicb.2023.1106945. eCollection 2023.